Beyond immune suppression: Revisiting adenosine A2A receptor biology in CD8+ T-cell differentiation, metabolic fitness and cancer immunotherapy
- 1Department of Medicine and Hematology and Oncology Division, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Abstract
Extracellular adenosine is a major immunosuppressive metabolite of the tumor microenvironment and a key barrier to anti-tumor immunity. Generated from ATP by the ectonucleotidases CD39 and CD73, it signals mainly through the high-affinity A2A adenosine receptor (A2AR). Although A2AR is regarded as an inhibitory immune checkpoint, recent work shows that its functions extend beyond immediate effector suppression to the regulation of metabolic fitness, mitochondrial homeostasis, and CD8+ T-cell differentiation. Notably, both sustained A2AR activation and complete receptor deficiency can drive terminal exhaustion through distinct mechanisms, and CD73 and extracellular adenosine are not biologically equivalent. Here we summarize adenosine signaling, the cell-specific roles of the A2AR axis, and the clinical development of A2AR-targeting immunotherapies. We identify the principal obstacles to therapeutic translation and advance biomarker-guided, calibrated modulation of A2AR signaling as a testable hypothesis rather than an established therapeutic principle, one that now requires comparative exposure–response and longitudinal intervention studies.
Related
- Revisiting the use of adenosine deaminase in cerebrospinal fluid analysis for infectious meningoencephalitis
- Elevated Adenosine Kinase and Decreased ENTPD1 mRNA Levels in Peripheral Blood Leukocytes of Patients with MASLD Differentiate Metabolic Dysfunction-Associated Steatohepatitis from Hepatic Steatosis.
- Revisiting alpha-fetoprotein thresholds for hepatocellular carcinoma surveillance in the metabolic dysfunction-associated steatotic liver disease era: time for an evidence-based recalibration.
- Cortical and metabolic brain development during pubertal hormone suppression
- Metabolic signature of phosphoethanolamine and arginine pathways predicts prognosis and immunotherapy resistance in lung adenocarcinoma
BibTeX
@article{kashyap2026beyond,
title = {{Beyond immune suppression: Revisiting adenosine A2A receptor biology in CD8+ T-cell differentiation, metabolic fitness and cancer immunotherapy}},
author = {Sujit Kashyap and Bashir Lawal and Bin Zhang},
journal = {Human Vaccines \& Immunotherapeutics},
year = {2026},
month = nov,
doi = {10.1080/21645515.2026.2753297},
url = {https://doi.org/10.1080/21645515.2026.2753297},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Beyond immune suppression: Revisiting adenosine A2A receptor biology in CD8+ T-cell differentiation, metabolic fitness and cancer immunotherapy
AU - Sujit Kashyap
AU - Bashir Lawal
AU - Bin Zhang
PY - 2026
DA - 2026/11/09
JO - Human Vaccines & Immunotherapeutics
DO - 10.1080/21645515.2026.2753297
UR - https://doi.org/10.1080/21645515.2026.2753297
AB - Extracellular adenosine is a major immunosuppressive metabolite of the tumor microenvironment and a key barrier to anti-tumor immunity. Generated from ATP by the ectonucleotidases CD39 and CD73, it signals mainly through the high-affinity A2A adenosine receptor (A2AR). Although A2AR is regarded as an inhibitory immune checkpoint, recent work shows that its functions extend beyond immediate effector suppression to the regulation of metabolic fitness, mitochondrial homeostasis, and CD8+ T-cell differentiation. Notably, both sustained A2AR activation and complete receptor deficiency can drive terminal exhaustion through distinct mechanisms, and CD73 and extracellular adenosine are not biologically equivalent. Here we summarize adenosine signaling, the cell-specific roles of the A2AR axis, and the clinical development of A2AR-targeting immunotherapies. We identify the principal obstacles to therapeutic translation and advance biomarker-guided, calibrated modulation of A2AR signaling as a testable hypothesis rather than an established therapeutic principle, one that now requires comparative exposure–response and longitudinal intervention studies.
SN - 2164-5515
SN - 2164-554X
ER -